Anti-il-12 antibodies, compositions, methods and uses
Details for Australian Patent Application No. 2001281137 (hide)
International Classifications
Event Publications
15 March 2007 Application Accepted
Published as AU-B-2001281137
12 July 2007 Standard Patent Sealed
7 January 2010 Extension of Term of Standard Patents
Centocor, Inc The earliest first regulatory approval date provided by the patentee 29 Jul 2009 For the goods STELARA ustekinumab
22 April 2010 Extension of Term of Standard Patents
Centocor, Inc The earliest first regulatory approval date provided by the patentee 28 Jul 2009 For the goods STELARA ustekinumab Address for service in Australia: Shelston IP Level 21 60 Margaret Street Sydney NSW 2000
16 September 2010 Extension granted
Centocor, Inc The earliest first regulatory approval date provided by the patentee 28 Jul 2009 For the goods STELARA ustekinumab Extension of Term of patent pursuant to Section 77 expires on 28 Jul 2024
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser